Katharina Meier Julia Holstein Farzan Solimani Jens Waschke Kamran Ghoreschi
10.3389/fimmu.2020.588315
Front Immunol
2020 Oct 27;11:588315.
t follicular regulatory (tfr) cell apremilast autoimmunity blistering disorders pemphigus vulgaris (pv)
CC BY
https://pubmed.ncbi.nlm.nih.gov/33193415/
Pemphigus / drug therapy Phosphodiesterase 4 Inhibitors / therapeutic use Thalidomide / analogs & derivatives
Pemphigus / drug therapy Phosphodiesterase 4 Inhibitors / therapeutic use Thalidomide / analogs & derivatives Case Reports Research Support, Non-U.S. Gov't Drug Resistance Female Humans Middle Aged Thalidomide / therapeutic use Phosphodiesterase 4 Inhibitors Thalidomide apremilast
PMC7653172
33193415
Case Report: Apremilast for Therapy-Resistant Pemphigus Vulgaris
2020